A new article entitled “Can enhanced external counterpulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting?” written by Amr A, Abdelwahab and Ayman M. Elsaied at Al- Hayet Cardiology Centre at Tanta University, in Tanta, Egypt, has been published in The Egyptian Heart Journal. This randomized study enrolled 42 patients with ischemic cardiomyopathy (ICM) post coronary artery bypass grafting (CABG) and demonstrated the successful use of EECP therapy to relieve or improve the symptoms of angina or heart failure when combined with medical treatment. Teh EECP group received 35 sessions of EECP in addition to their medical treatment and the control was limited to medical treatment only. When the groups were followed up for 3 months, EECP treated group (n=20) showed a marked improvement in a reduction of the frequency of angina, their need for sublingual nitrates per week and re-hospitalization needed when compared to the control group (n=22), despite similar severity of symptons in both groups. For more information go to: https://www.sciencedirect.com/journal/the-egyptian-heart-journal/articles-in-press
Recent News
Recently Published Case Study Explores the Possibility of Using EECP Therapy to Treat Long – COVID POTS
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Join the IEECPS!
The IEECPS gives you the opportunity to make a contribution and be part of a world wide effort to improve the utilization of EECP Therapy to slow down or prevent the progression of cardiovascular disease.